These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32793288)

  • 1. Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma.
    Sun JR; Kong CF; Lou YN; Yu R; Qu XK; Jia LQ
    Front Genet; 2020; 11():796. PubMed ID: 32793288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer.
    Liu M; Khushbu RA; Chen P; Hu HY; Tang N; Ou-Yang DJ; Wei B; Zhao YX; Huang P; Chang S
    Front Oncol; 2021; 11():705929. PubMed ID: 34722250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.
    Zhang D; Duan Y; Cun J; Yang Q
    Front Genet; 2019; 10():278. PubMed ID: 30984247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic alternative splicing signatures and underlying regulatory network in esophageal carcinoma.
    Xie ZC; Wu HY; Ma FC; Dang YW; Peng ZG; Zhou HF; Chen G
    Am J Transl Res; 2019; 11(7):4010-4028. PubMed ID: 31396315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing.
    Gong S; Song Z; Spezia-Lindner D; Meng F; Ruan T; Ying G; Lai C; Wu Q; Liang Y
    Front Genet; 2020; 11():534. PubMed ID: 32595697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Oncol; 2020; 10():1257. PubMed ID: 32793502
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
    Yang L; He Y; Zhang Z; Wang W
    PeerJ; 2019; 7():e8245. PubMed ID: 31844595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data.
    Ye P; Yang Y; Zhang L; Zheng G
    Front Oncol; 2021; 11():658262. PubMed ID: 34676158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.
    Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M
    J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307
    [No Abstract]   [Full Text] [Related]  

  • 11. A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma.
    Zhu L; Wang Z; Sun Y; Giamas G; Stebbing J; Yu Z; Peng L
    Front Oncol; 2021; 11():778637. PubMed ID: 35004299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
    Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
    J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
    Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
    J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.
    Liu Y; Jia W; Li J; Zhu H; Yu J
    Front Oncol; 2020; 10():587343. PubMed ID: 33117720
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Alternative Splicing Factors hnRNP G and Fox-2 in the Progression and Prognosis of Esophageal Cancer.
    Zheng Y; Niu X; Xue W; Li L; Geng Q; Fan Z; Zhao J
    Dis Markers; 2022; 2022():3043737. PubMed ID: 36466711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
    Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
    Zhang B; Yang L; Wang X; Fu D
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.